Cosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M

Cosmos Health's subsidiary, CosmoFarm, reported record Q2 2026 revenue exceeding $15 million, leading to an annualized run-rate of over $60 million. This marks a 4.3x increase in revenue since the company's acquisition in 2017, with a compound annual growth rate (CAGR) of approximately 18%. The company is leveraging robotics, automation, and AI-enabled systems to potentially support an additional $40 million in annual revenue, aiming for a total annualized revenue above $100 million. Cosmos Health has set a 2029 revenue guidance of $200.6 million.